Medpace (MEDP)
(Delayed Data from NSDQ)
$333.45 USD
-0.35 (-0.10%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $334.83 +1.38 (0.41%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Medpace Holdings, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 245 | 28 | 461 | 278 | 132 |
Receivables | 298 | 253 | 186 | 161 | 156 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 50 | 52 | 43 | 35 | 29 |
Total Current Assets | 594 | 334 | 691 | 474 | 317 |
Net Property & Equipment | 121 | 110 | 93 | 85 | 47 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 74 | 48 | 25 | 1 | 0 |
Intangibles | 698 | 700 | 704 | 709 | 717 |
Deposits & Other Assets | 25 | 21 | 17 | 9 | 9 |
Total Assets | 1,657 | 1,353 | 1,660 | 1,391 | 1,143 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 32 | 33 | 26 | 27 | 22 |
Current Portion Long-Term Debt | 0 | 50 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 293 | 210 | 159 | 134 | 109 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 600 | 510 | 372 | 279 | 211 |
Total Current Liabilities | 925 | 803 | 557 | 440 | 343 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 1 | 1 | 14 | 13 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 28 | 23 | 18 | 16 | 16 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,098 | 966 | 707 | 585 | 417 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 803 | 771 | 728 | 696 | 667 |
Retained Earnings | -222 | -360 | 235 | 115 | 68 |
Other Equity | -10 | -12 | -5 | 0 | -3 |
Treasury Stock | 12 | 13 | 5 | 6 | 6 |
Total Shareholder's Equity | 559 | 386 | 953 | 806 | 726 |
Total Liabilities & Shareholder's Equity | 1,657 | 1,353 | 1,660 | 1,391 | 1,143 |
Total Common Equity | 559 | 386 | 953 | 806 | 726 |
Shares Outstanding | 30.60 | 31.10 | 35.90 | 35.70 | 36.00 |
Book Value Per Share | 18.27 | 12.42 | 26.54 | 22.57 | 20.17 |
Fiscal Year End for Medpace Holdings, Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 511 | 407 | 245 | 95 | 39 |
Receivables | 301 | 279 | 298 | 293 | 275 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 61 | 59 | 50 | 61 | 65 |
Total Current Assets | 873 | 745 | 594 | 449 | 379 |
Net Property & Equipment | 122 | 119 | 121 | 115 | 115 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 75 | 75 | 74 | 59 | 52 |
Intangibles | 697 | 698 | 698 | 699 | 699 |
Deposits & Other Assets | 18 | 20 | 25 | 21 | 22 |
Total Assets | 1,920 | 1,796 | 1,657 | 1,487 | 1,407 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 27 | 24 | 32 | 29 | 34 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 55 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 293 | 271 | 293 | 265 | 232 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 673 | 661 | 600 | 555 | 532 |
Total Current Liabilities | 993 | 957 | 925 | 849 | 852 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 2 | 2 | 1 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 29 | 28 | 23 | 23 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,156 | 1,124 | 1,098 | 1,016 | 1,016 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 819 | 815 | 803 | 796 | 785 |
Retained Earnings | -31 | -119 | -222 | -300 | -371 |
Other Equity | -13 | -12 | -10 | -13 | -11 |
Treasury Stock | 12 | 12 | 12 | 12 | 12 |
Total Shareholder's Equity | 764 | 672 | 559 | 471 | 391 |
Total Liabilities & Shareholder's Equity | 1,920 | 1,796 | 1,657 | 1,487 | 1,407 |
Total Common Equity | 764 | 672 | 559 | 471 | 391 |
Shares Outstanding | 31.00 | 30.90 | 30.60 | 30.60 | 30.50 |
Book Value Per Share | 24.63 | 21.73 | 18.27 | 15.39 | 12.82 |